B Group, Inc. Diversified Active

CIK: 0002043476 · Show all filings

Period: Q4 2024 (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $163,598 (100.0% shares, 0.0% debt)

Holdings (18)

INVESCO QQQ TR 34.4%
Value ($000) $56,235 Shares 110,000 Est. Cost $511.23 Unrealized
ADMA ADMA BIOLOGICS INC 24.0%
Value ($000) $39,231 Shares 2,287,542 Est. Cost $18.81 Unrealized 0.0%
INSM INSMED INC 14.8%
Value ($000) $24,164 Shares 350,000 Est. Cost $72.02 Unrealized 0.0%
ZLAB ZAI LAB LTD 6.4%
Value ($000) $10,476 Shares 400,000 Est. Cost $26.19 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 4.5%
Value ($000) $7,341 Shares 992,000 Est. Cost $9.27 Unrealized 0.0%
AKERO THERAPEUTICS INC 4.4%
Value ($000) $7,233 Shares 260,000 Est. Cost $27.82 Unrealized
CLLS CELLECTIS S A 3.4%
Value ($000) $5,547 Shares 3,081,501 Est. Cost $1.80 Unrealized
AURA AURA BIOSCIENCES INC 2.4%
Value ($000) $3,885 Shares 472,576 Est. Cost $9.41 Unrealized 0.0%
SGHT SIGHT SCIENCES INC 1.4%
Value ($000) $2,291 Shares 629,370 Est. Cost $4.55 Unrealized 0.0%
TSHA TAYSHA GENE THERAPIES INC 1.0%
Value ($000) $1,670 Shares 965,556 Est. Cost $2.07 Unrealized 0.0%
ULTRAGENYX PHARMACEUTICAL IN 0.8%
Value ($000) $1,241 Shares 29,500 Est. Cost $42.07 Unrealized
SYRE SPYRE THERAPEUTICS INC 0.7%
Value ($000) $1,164 Shares 50,000 Est. Cost $29.32 Unrealized 0.0%
ASMB ASSEMBLY BIOSCIENCES INC 0.5%
Value ($000) $799 Shares 50,651 Est. Cost $16.10 Unrealized 0.0%
APGE APOGEE THERAPEUTICS INC 0.4%
Value ($000) $680 Shares 15,000 Est. Cost $51.00 Unrealized 0.0%
CORVUS PHARMACEUTICALS INC 0.3%
Value ($000) $535 Shares 100,000 Est. Cost $5.35 Unrealized
BNTX BIONTECH SE 0.2%
Value ($000) $399 Shares 3,500 Est. Cost $113.95 Unrealized
ORKA ORUKA THERAPEUTICS INC 0.2%
Value ($000) $388 Shares 20,000 Est. Cost $24.40 Unrealized 0.0%
RARE ULTRAGENYX PHARMACEUTICAL IN 0.2%
Value ($000) $320 Shares 7,596 Est. Cost $49.61 Unrealized 0.0%